- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
9541 Participants Needed
Trial Details
Key Eligibility Criteria
368 Participants Needed
Trial Details
Key Eligibility Criteria
760 Participants Needed
Trial Details
Key Eligibility Criteria
698 Participants Needed
Trial Details
Key Eligibility Criteria
2749 Participants Needed
Trial Details
Key Eligibility Criteria
992 Participants Needed
Trial Details
Key Eligibility Criteria
1719 Participants Needed
Trial Details
Key Eligibility Criteria
660 Participants Needed
Trial Details
Key Eligibility Criteria
12547 Participants Needed
Trial Details
Key Eligibility Criteria
350 Participants Needed
Trial Details
Key Eligibility Criteria
1172 Participants Needed
Trial Details
Key Eligibility Criteria
1840 Participants Needed
Trial Details
Key Eligibility Criteria
750 Participants Needed
Trial Details
Key Eligibility Criteria
250 Participants Needed
Trial Details
Key Eligibility Criteria
10000 Participants Needed
Trial Details
Key Eligibility Criteria
480 Participants Needed
Trial Details
Key Eligibility Criteria
16700 Participants Needed
Trial Details
Key Eligibility Criteria
412 Participants Needed
Trial Details
Key Eligibility Criteria
1250 Participants Needed
Trial Details
Key Eligibility Criteria
2000 Participants Needed
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Trial Details
Key Eligibility Criteria
1395 Participants Needed
Trial Details
Key Eligibility Criteria
15374 Participants Needed
Trial Details
Key Eligibility Criteria
2592 Participants Needed
Trial Details
Key Eligibility Criteria
5018 Participants Needed
Trial Details
Key Eligibility Criteria
163 Participants Needed
Trial Details
Key Eligibility Criteria
220 Participants Needed
Trial Details
Key Eligibility Criteria
660 Participants Needed
Trial Details
Key Eligibility Criteria
415 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Fairhaven, MA 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Fairhaven, MA is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Fairhaven, MA several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder, MDMA-Assisted Therapy for Post-Traumatic Stress Disorder and Imiquimod Cream for Basal Cell Carcinoma to the Power online platform.